Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J-P Arnault

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Clinical and Experimental Dermatology|December 6, 2014
Nonuraemic calciphylaxis: response to treatment with pamidronate and negative pressure therapyA Lorriaux, G Chaby, F Dhaille, et al.
Annales De Dermatologie Et De Venereologie|April 23, 2026
Systematic skin cancer screening in patients treated with biologics for chronic inflammatory rheumatic diseases: an 11-year experienceC Elbaz, F Lombart, B Batteux, et al.
Dermatology Online Journal|November 4, 2020
Severe erosive gingivostomatitis in a patient treated by vedolizumabL Semeria, A Dadban, F Brazier, et al.
European Journal of Cancer (Oxford, England : 1990)|November 2, 2018
Update of survival and cost of metastatic melanoma with new drugs: Estimations from the MelBase cohortM Kandel, C Allayous, S Dalle, et al.
Annales De Dermatologie Et De Venereologie|February 7, 2024
The combination of ipilimumab and nivolumab is still not reimbursed for BRAF-mutated melanoma patients in France: An unacceptable medical situation that raises ethical concernsM Amini-Adle, J-P Arnault, F Aubin, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Clinical and Experimental Dermatology|December 6, 2014
Nonuraemic calciphylaxis: response to treatment with pamidronate and negative pressure therapyA Lorriaux, G Chaby, F Dhaille, et al.
Annales De Dermatologie Et De Venereologie|April 23, 2026
Systematic skin cancer screening in patients treated with biologics for chronic inflammatory rheumatic diseases: an 11-year experienceC Elbaz, F Lombart, B Batteux, et al.
Dermatology Online Journal|November 4, 2020
Severe erosive gingivostomatitis in a patient treated by vedolizumabL Semeria, A Dadban, F Brazier, et al.
European Journal of Cancer (Oxford, England : 1990)|November 2, 2018
Update of survival and cost of metastatic melanoma with new drugs: Estimations from the MelBase cohortM Kandel, C Allayous, S Dalle, et al.
Annales De Dermatologie Et De Venereologie|February 7, 2024
The combination of ipilimumab and nivolumab is still not reimbursed for BRAF-mutated melanoma patients in France: An unacceptable medical situation that raises ethical concernsM Amini-Adle, J-P Arnault, F Aubin, et al.
Pageof 2